Please login to the form below
constipation
This page shows the latest constipation news and features for those working in and with pharma, biotech and healthcare.
Immunology keeps Shire figures solid as Takeda takeover nears
HAE, prucalopride (SHP555) for chronic idiopathic constipation, and calaspargase pegol (SHP663) for the treatment of acute lymphoblastic leukaemia (ALL).
Latest news
-
Mallinckrodt pays $1.2bn for Sucampo Pharma
As 2017 drew to a close, Mallinckrodt signed a deal to buy Sucampo Pharma of the US - and its constipation drug Amitizia - for $1.2bn. ... Amitizia is the prize asset in the deal, with FDA approvals in hand for three indications - chronic idiopathic
-
NICE backs Allergan's IBS therapy Truberzi
includes Linzess (linaclotide) for IBS with constipation.
-
FDA fast-tracks Pfizer and Lilly's tanezumab
unpleasant side effects such as severe constipation.
-
FDA approves Synergy's constipation drug Trulance
Synergy Pharma is celebrating after the FDA approved Trulance, its drug for the treatment of chronic idiopathic constipation (CIC) in adults. ... There are around 42 million people in the US who suffer from constipation, according to the National
-
Valeant's proposed sale of Salix to Takeda 'in jeopardy'
That push will also extend to opioid-induced constipation drug Relistor (methylnaltrexone bromide), and comments made by the company in its announcement lend some credence to the rumours of the breakdown
More from news
Approximately 9 fully matching, plus 76 partially matching documents found.
Latest Intelligence
-
Erectile dysfunction, constipation, vaginal dryness and other laughing matters
Erectile dysfunction, constipation, vaginal dryness and other laughing matters. Humour in healthcare brand communications: when and where is it appropriate? ... Diarrhoea, constipation, flatulence, leaky bladder, vaginal dryness - it’s all fertile
-
Taking a lean and careful approach
His pioneering research culminated in the drug, Trulance, which has received FDA approval and is being used to treat irritable bowel syndrome and chronic constipation.
-
Deal Watch March 2016
$110. AstraZeneca/ Kyowa Hakko Kirin. Opioid-induced constipation – Moventig. Licence. $70.
-
Oral biologics delivery still elusive
years. Among a newer generation of orally-delivered peptides is Ironwood Pharma's peptide drug Linzess/Constella (linaclotide) - which debuted in 2012 for constipation associated with irritable bowel syndrome.
-
Medius Deal Watch table for March 2015
941. AstraZeneca / Daiichi Sankyo. Co-commercialisation US . Marketed Movantik (naloxegol) for opioid induced constipation.
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Ironwood appoints Edward Owens to board
irritable bowel syndrome and constipation. “
-
Norgine’s Karen Hockey promoted to head of global marketing
Norgine’ s Karen Hockey promoted to head of global marketing. Appointment follows nearly two years as global brand manager for constipation treatment Movicol. ... Hockey's promotion comes after nearly two years as global brand manager for constipation
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
FCB Halesway
Stroke prevention in atrial fibrillation. Galen. Branded generics. Constipation. Vitamin D supplements.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Account Manager, Healthcare Advertising
-
£30 - 38, 000 (or -)
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Senior Medical Writer, Principal Medical Writer, Scientific Dire...
-
£40000 - £75000 Bonus Benefits
-
Associate Scientific Director
-
Salary TBC
-
Systematic Review Lead- London
-
Negotiable
-
Healthcare PR Senior Account Manager
-
Salary TBC
- Integrated Brand/ Digital Senior Account Director, London
-
Excellent package
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Account Director, Healthcare Communications Agency
-
£54, 000- £60, 000
-
Senior Medical Writer
-
Salary is DOE
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Account Director or Senior Account Director
-
Salary TBC
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Senior Writer, Healthcare Advertising, London
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
Subscribe to our email news alerts
- IPA’s new training course, Silver Buck launched and ARK moves office
- NHS wins legal fight with pharma over off-label Avastin
- Gilead and ViiV among winners at PM Society Digital Awards
- The critical role of science in healthcare communications
- UK pharma to work with innovation network on NHS uptake
- Bayer roll-out of haemophilia drug Jivi gathers pace
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
